Peter Angus

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.

Paul J Clark, Patricia C Valery, Simone I Strasser, Martin Weltman, Alexander J Thompson, Miriam Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, et al.

Journal article  |  2023  |  Dig Dis Sci

BACKGROUND AND AIMS: In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia's u..

Alcohol intake is associated with a decreased risk of developing primary biliary cholangitis

Janine Adele French, Paul Gow, Steven Simpson-Yap, Kate Collins, Justin Ng, Peter W Angus, Ingrid AF van der Mei

Journal article  |  2022  |  WORLD JOURNAL OF HEPATOLOGY

BACKGROUND: Primary biliary cholangitis (PBC) is a chronic progressive liver disease of unknown aetiology characterised by immune-..

Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

Samuel Al Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone Strasser, William Sievert, Paul Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, et al.

Journal article  |  2022  |  JOURNAL OF INFECTIOUS DISEASES

BACKGROUND: We evaluated the patterns of peripheral Toll-like receptor (TLR) signaling activity and the expression of TLRs and nat..

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up.

Paul J Clark, Patricia C Valery, James Ward, Simone I Strasser, Martin Weltman, Alexander Thompson, Miriam T Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, et al.

Journal article  |  2022  |  BMC Gastroenterol

BACKGROUND: First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospectiv..

Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic rats

Lakmie S Gunarathne, Indu G Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W Angus, Chandana B Herath

Journal article  |  2022  |  HEPATOLOGY COMMUNICATIONS

Splanchnic vasodilatation contributes to the development and aggravation of portal hypertension (PHT). We previously demonstrated ..

Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

Samuel AL Hall, Gareth S Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone Strasser, William Sievert, Paul Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, Kathy Jackson, Margaret Littlejohn, et al.

Journal article  |  2022  |  ALIMENTARY PHARMACOLOGY & THERAPEUTICS

BACKGROUND AND AIMS: Current guidelines recommend long-term nucleot(s)ide analogue (NA) therapy for patients with HBeAg-negative c..

Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant

Brooke Chapman, Su Kah Goh, Frank Parker, Sarah Romero, Marie Sinclair, Paul Gow, Ronald Ma, Peter Angus, Robert Jones, Jacqueline Luke, Vijayaragavan Muralidharan, Adam Testro

Journal article  |  2022  |  CLINICAL NUTRITION ESPEN

BACKGROUND & AIMS: Malnutrition and sarcopenia are associated with increased morbidity and mortality in cirrhosis but conflicting ..

Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis

Paul J Gow, Marie Sinclair, Phoebe A Thwaites, Peter W Angus, Brooke Chapman, Ryma Terbah, Adam G Testro

Journal article  |  2022  |  EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

BACKGROUND/AIM: Therapeutic options are limited for patients with hepatorenal syndrome (HRS), diuretic refractory ascites and hepa..

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments.

Chandana B Herath, Peter W Angus, Jonel Trebicka

Journal article  |  2022  |  Front Physiol

Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver

Indu G Rajapaksha, Lakmie S Gunarathne, Khashayar Asadi, Ross Laybutt, Sof Andrikopoulous, Ian E Alexander, Mathew J Watt, Peter W Angus, Chandana B Herath

Journal article  |  2021  |  HEPATOLOGY COMMUNICATIONS

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is frequently associated with type ..